Dermira (DERM) Misses Q1 EPS by 4c

Dermira (NASDAQ: DERM) reported Q1 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $19.4 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Is Treasury selloff a major issue for stock market bulls?
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)